Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04148001 · ClinicalTrials.gov registry record
Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients
A clinical trial of Homozygous Familial Hypercholesterolemia (HoFH), sponsored by REGENXBIO.
- Completed
- Registry status
- 4
- Enrollment target
- 1
- Study location
NCT04148001 is a study of Homozygous Familial Hypercholesterolemia (HoFH) that has completed, run by REGENXBIO. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04148001, a study of Homozygous Familial Hypercholesterolemia (HoFH), has completed, sponsored by REGENXBIO.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to help identify patients with HoFH due to mutations in the LDLR as confirmed by genotyping.
Conditions Studied
Study Locations (1)
Florida
- Excel Medical Clinical Trials, LLC - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-12-04 |
| Est. Completion | 2020-04-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04148001
The ClinicalTrials.gov registry entry for NCT04148001 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is REGENXBIO, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Homozygous Familial Hypercholesterolemia (HoFH) appearing as the primary indexed condition, and to 0 interventions.
NCT04148001 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04148001 about?
NCT04148001 is a clinical study titled "Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients". This study is designed to help identify patients with HoFH due to mutations in the LDLR as confirmed by genotyping.
What is the current status of trial NCT04148001?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2019-12-04. Estimated completion is 2020-04-08.
What conditions does trial NCT04148001 study?
This clinical trial studies the following conditions: Homozygous Familial Hypercholesterolemia (HoFH).
Who is sponsoring clinical trial NCT04148001?
This trial is sponsored by REGENXBIO, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04148001 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Homozygous Familial Hypercholesterolemia (HoFH)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.